The targeted IL-27 appeared to modulate several changes that would be consistent with an anti-tumor effect, including upregulation in the IFN and Interferon regulatory factor (IRF) signaling, oxidative phosphorylation, JAK/STAT signaling, and eukaryotic initiation factor 2 (EIF2) signaling. The gene discussed is SOAT1; the disease is neoplasm.